PR CENTER

NEWGLAB PR Center

One of the missions of NewG Lab Pharma
(NGLP) will be to develop novel anticancer
therapeutics that extend the life of cancer patients
without compromising the quality of life.

Media

NOVEMBER 13, 2009
Yvar Verhoeven presentation 13112009 at Johns Hopkins.

Yvar Verhoeven presentation 13112009 at Johns Hopkins.


- Yvar Verhoeven meets students after his presentation at John's Hopkins, November 13th, 2009.


- The first patient to be treated with Dr. Ko's 3BP compound.


- A Translational Study "Case Report" on the Small Molecule "Energy Blocker" 3-Bromopyruvate (3BP) 

  as a Potent Anticancer Agent: From Bench Side to Bedside(2012)



https://www.youtube.com/watch?v=Jm7f5FOWqvI&feature=youtu.be (part 1)


https://www.youtube.com/watch?v=aOszMBpMK9s (part 2)


https://www.youtube.com/watch?v=aOszMBpMK9s&feature=youtu.be (part 3)


https://www.youtube.com/watch?v=DF3Uvo9mnPM&feature=youtu.be (part 5)

 
Yvar_001.png

CONTACT US